je.st
news
Home
› Moberg Pharma announces issue of U.S. Patent related to MOB-015 for the treatment of Onychomycosis
Moberg Pharma announces issue of U.S. Patent related to MOB-015 for the treatment of Onychomycosis
2015-02-11 13:08:14| Appliances - Topix.net
Moberg Pharma AB today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,952,070, relating to its topical treatment MOB-015 for onychomycosis.
Tags: of
related
issue
treatment
Category:Consumer Goods and Services